Shire's drug for rare swelling disorder wins European panel green light


A European Medicines Agency panel on Friday recommended approving a potential blockbuster drug from Shire Plc to treat patients aged 12 and older with a rare hereditary disease that causes swelling in different parts of the body. FILE PHOTO: An aircract flies over The European Medecines Agency and Ernst and Young's building in Canary Wharf on a clear morning in London, Britain, August 8, 2018.



from Biotech News